Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

William Behrens

Orthopaedic Surgery Saint Louis, MO Medical Doctor

NPI 1770012767 CMS profile 8802626

12639 Old Tesson Rd, Saint Louis, MO 63128

Open in the dashboard

General payments

$26,667

135 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Behrens of Saint Louis, MO is reported in the CMS Open Payments database as having received $26,667 across 135 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,150 12
2024 General $3,213 26
2023 General $12,047 69
2022 General $8,830 23
2021 General $195 2
2020 General $1,232 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Behrens
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Behrens were reported at $1,150. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year William Behrens Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $1,232 $312 $75–$1,860 $114
2021 $195 $520 $117–$2,495 $132
2022 $8,830 $598 $128–$2,731 $149
2023 $12,047 $461 $128–$2,264 $160
2024 $3,213 $497 $134–$2,475 $164
2025 $1,150 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Smith+Nephew, Inc. $6,728 11 payments
  2. Encore Medical, LP $6,252 27 payments
  3. Ortho Development Corporation $4,685 26 payments
  4. Medacta USA, Inc. $3,233 25 payments
  5. Elite Orthopedics, LLC $1,303 7 payments
  6. Zimmer Biomet Holdings, Inc. $1,297 8 payments
  7. Davol Inc. $993 2 payments
  8. Stryker Corporation $880 11 payments
  9. DePuy Synthes Sales Inc. $427 4 payments
  10. Orthalign Inc $361 3 payments
  11. Other $507 11 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Travel and Lodging $9,095 24 payments
  2. Food and Beverage $7,945 105 payments
  3. Education $7,228 4 payments
  4. Honoraria $2,400 2 payments
Products named General payments · program years 2020–2025
  1. DJO SURGICAL Joint Implants $3,317 16 payments
  2. DJO SURGICAL Joint Implants $2,320 10 payments
  3. AMISTEM $2,191 13 payments
  4. DJO SURGICAL Joint Implants $1,694 5 payments
  5. Balance Knee Revision System $1,571 6 payments
  6. BKS Uni $1,553 6 payments
  7. DJO SURGICAL Joint Implants $1,242 6 payments
  8. Persona $1,147 7 payments
  9. DJO SURGICAL Joint Implants $821 2 payments
  10. MAKO $759 8 payments
  11. Other $6,005 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

940

Median for Orthopedic Surgery: 203

Drug cost

$5,410

Median for Orthopedic Surgery: $1,433

Branded share of claims

20.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 155 $1,325
Gabapentin Generic 85 $649
Meloxicam Generic 332 $578
Celecoxib Generic 42 $487
Ibuprofen Generic 57 $422
Indomethacin Generic 33 $375
Cephalexin Generic 31 $357
Cyclobenzaprine Hcl Generic 51 $349
Diclofenac Sodium Generic 13 $205
Methocarbamol Generic 17 $177

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$111,739

Of which drugs: $5,903

Medicare patients

297

Average age 75

Services billed

2,269

185 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 39%
Depression 38%
Ischemic heart disease 37%
Chronic kidney disease 33%
Atrial fibrillation 26%
Heart failure 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 82 936 $710

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

135 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record